Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-26-034066

President & CIO sold 335,174 shares at an average $36.88 ($12,360,813)

  • President & CIO acquired 335,174 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sukhatme Mayukh · President & CIO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-19 Exercise or conversion : show line 1 in the form +172,899 $3.85 $665,661 18,803,638 D
2026-08-19 Sale : show line 2 in the form −172,899 $37.17 $6,426,656 18,630,739 D
2026-08-20 Exercise or conversion : show line 3 in the form +17,519 $3.85 $67,448 18,648,258 D
2026-08-20 Sale : show line 4 in the form −17,519 $37.30 $653,459 18,630,739 D
2026-08-21 Exercise or conversion : show line 5 in the form +144,756 $3.85 $557,311 18,775,495 D
2026-08-21 Sale : show line 6 in the form −144,756 $36.48 $5,280,699 18,630,739 D
Open-market sales · 335,174 sh · avg $36.88 · $12,360,813

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-08-19 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −172,899 13,386,638 D
2026-08-20 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −17,519 13,369,119 D
2026-08-21 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −144,756 13,224,363 D
Loading xslF345X06/form4.xml…